Press Releases

Bristol Myers Squibb Rakes In Nearly $2B While Suing to Block Cost-Lowering Program

Economic Security and Corporate Power
July 26, 2024

Pharmaceutical giant Bristol Myers Squibb announced $1.7 billion in Q2 2024 earnings today amid the company’s ongoing legal challenge to block the Biden-Harris administration from lowering medication costs for millions of Americans. The pharmaceutical giant is one of several companies appealing recent court rulings defending Medicare’s negotiation

Press Releases

Judge Blocks Grocery Merger, Promising Relief for Millions of Shoppers

Economic Security and Corporate Power
July 25, 2024

Today, Colorado Judge Andrew J. Luxen granted a preliminary injunction to temporarily block the proposed $25 billion merger between Kroger and Albertsons. As government watchdog Accountable.US has documented, the proposed merger would be detrimental to millions of Americans dealing with big food industry price-gouging. The trial is set to begin Sep

Press Releases

Pharma Giant AstraZeneca Suing to End Cost-Lowering Program Boasts Nearly $2B in Earnings

Economic Security and Corporate Power
July 25, 2024

AstraZeneca announced nearly $2 billion in Q2 2024 earnings today—a shocking total earned amid the company’s ongoing legal challenge to block the Biden-Harris administration from lowering medication costs for millions of Americans. The pharmaceutical giant is one of five companies appealing recent court rulings defending Medicare’s negotiation auth

Press Releases

More Big Banks Boast Bigger Earnings While Insisting On Junk Fees, Predatory Interest Rates

Economic Security and Corporate Power
July 17, 2024

Today, U.S. Bancorp and Synchrony Bank announced $2.25 billion in combined Q2 2024 earnings, up 17.7% and 13%, respectively, while harming consumers with junk fees and predatory interest rates. An Accountable.US review found U.S. Bancorp raked in $277.3 million from fees on deposit accounts, including $55 million from overdraft fees, between Januar

back to top